Sign In
Buy CTSO
$0.489
+0.0090 (+1.88%)
At Close: Jun 03, 2026
CytoSorbents to Present at the Oppenheimer 31st Annual Healthcare Conference
07:00am, Friday, 12'th Mar 2021
MONMOUTH JUNCTION, N.J., March 12, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology
Cytosorbents' (CTSO) CEO Phillip Chan on Q4 2020 Results - Earnings Call Transcript
01:00am, Wednesday, 10'th Mar 2021
Cytosorbents' (CTSO) CEO Phillip Chan on Q4 2020 Results - Earnings Call Transcript
CytoSorbents: Q4 Earnings Insights
04:28pm, Tuesday, 09'th Mar 2021
Shares of CytoSorbents (NASDAQ:CTSO) moved higher in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share were up 91.67% year over year to ($0.01), which b
CytoSorbents Announces 2020 Financial and Operational Results
04:15pm, Tuesday, 09'th Mar 2021
MONMOUTH JUNCTION, N.J., March 9, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to tr
CytoSorbents to Present at the Cowen 41st Annual Health Care Conference
07:08am, Wednesday, 24'th Feb 2021
MONMOUTH JUNCTION, N.J., Feb. 24, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to tre
CytoSorbents 2021: Leadership and Growth in the "New Normal"
07:08am, Thursday, 18'th Feb 2021
MONMOUTH JUNCTION, N.J., Feb. 18, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to tre
CytoSorbents to Present at the 10th Annual SVB Leerink Global Healthcare Conference
07:08am, Tuesday, 16'th Feb 2021
MONMOUTH JUNCTION, N.J., Feb. 16, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to tre
MONMOUTH JUNCTION, N.J., Feb. 4, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to trea
CytoSorbents Appoints David D. Cox, PhD, MBA as Vice President - Global Regulatory Affairs
07:08am, Thursday, 21'st Jan 2021
MONMOUTH JUNCTION, N.J., Jan. 21, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to tre
CytoSorbents Announces Approval of CytoSorb® in Korea in Collaboration with Partner Fresenius Medical Care
07:08am, Tuesday, 19'th Jan 2021
MONMOUTH JUNCTION, N.J., Jan. 19, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to tre
CytoSorbents Appoints James Komsa as Vice President - U.S. Sales and Marketing
06:00am, Monday, 11'th Jan 2021
MONMOUTH JUNCTION, N.J., Jan. 11, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to tre
Health Canada Authorizes CytoSorb for Use in Hospitalized COVID-19 Patients
06:30am, Monday, 04'th Jan 2021
MONMOUTH JUNCTION, N.J., Jan. 4, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to trea
CytoSorbents Promotes Dr. Christian Steiner to Executive Vice President of Sales and Marketing
07:08am, Thursday, 17'th Dec 2020
MONMOUTH JUNCTION, N.J., Dec. 17, 2020 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to tre
Early CytoSorb Initiation Improves Hemodynamic Stabilization and Survival in New Septic Shock Study
06:45am, Wednesday, 09'th Dec 2020
MONMOUTH JUNCTION, N.J., Dec. 9, 2020 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to trea
CytoSorbents Launches International Campaign to Raise $100,000 for the Global Humanitarian Organization, CARE
07:08am, Wednesday, 02'nd Dec 2020
MONMOUTH JUNCTION, N.J., Dec. 2, 2020 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader that is commercializing its CytoSorb® blood purification technology
